http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102255176-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-218
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L11-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L11-45
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L11-00
filingDate 2014-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102255176-B1
titleOfInvention Coagulant composition for tofu and method for manufacturing tofu using same
abstract Even when the inorganic salt-based coagulant is distributed a lot, it has excellent dispersibility into soy milk, and there is no need to use a dedicated coagulation device equipped with a high-speed disperser. Even with agitation by a general low-speed stirrer, the coagulant composition for tofu is dispersed throughout the soy milk. It is a subject to provide a coagulant composition for tofu in which the flavor and texture of the tofu obtained by coagulation are improved. It provides a coagulant composition for tofu characterized by containing (a) an inorganic salt-based coagulant, (b) polyglycerin condensed ricinoleic acid ester, (c) lecithin and/or glycerindiacetyl tartaric acid fatty acid ester, and (d) an oily component. .
priorityDate 2013-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100831913-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4391332-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000106839-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-3255608-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453742508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550069
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448203525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24644
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412188633
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53629489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11164
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408335764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312853
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153388
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426071153
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5497163
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448452169

Total number of triples: 48.